We are live on ! Find out more
HI

Humankind Investments Portfolio holdings

AUM $175M
1-Year Est. Return 14.3%
This Fund
S&P 500
This Quarter Est. Return
-3.89%
1 Year Est. Return
+14.3%
3 Year Est. Return
+46.43%
5 Year Est. Return
+54.92%
10 Year Est. Return
–
AUM
$240M
AUM Growth
-$15.6M
Cap. Flow
-$5.02M
Cap. Flow %
-2.09%
Top 10 Hldgs %
67.5%
Holding
123
New
1
Increased
43
Reduced
64
Closed
8

Top Buys

Rank Stock Value
1
CTVA icon
Corteva
CTVA
+$249K
2
FMC icon
FMC
FMC
+$196K
3
GEHC icon
GE HealthCare
GEHC
+$135K
4
VZ icon
Verizon
VZ
+$133K
5
MRK icon
Merck
MRK
+$124K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$645K
2
BG icon
Bunge Global
BG
+$514K
3
ADM icon
Archer Daniels Midland
ADM
+$425K
4
AMZN icon
Amazon
AMZN
+$266K
5
DE icon
Deere & Co
DE
+$249K

Sector Composition

Rank Sector Weight
1 Technology 15.8%
2 Healthcare 14.28%
3 Consumer Staples 6.35%
4 Communication Services 4.25%
5 Materials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WMT icon
26
Walmart Inc
WMT
$890B
$1.51M 0.63%
28,302
-1,806
-6% -$96.1K
CF icon
27
CF Industries
CF
$17.3B
$1.19M 0.5%
13,916
-2,704
-16% -$214K
BMY icon
28
Bristol-Myers Squibb
BMY
$132B
$1.17M 0.49%
20,243
+991
+5% +$60.7K
HCA icon
29
HCA Healthcare
HCA
$89.5B
$1.12M 0.46%
4,542
+195
+4% +$53.4K
AMGN icon
30
Amgen
AMGN
$222B
$1.1M 0.46%
4,105
-741
-15% -$185K
SYK icon
31
Stryker
SYK
$130B
$1.04M 0.43%
3,822
+75
+2% +$21.5K
DHR icon
32
Danaher
DHR
$144B
$987K 0.41%
4,487
-511
-10% -$114K
AGCO icon
33
AGCO
AGCO
$7.2B
$979K 0.41%
8,273
-470
-5% -$59.7K
BDX icon
34
Becton Dickinson
BDX
$48.2B
$977K 0.41%
3,778
-367
-9% -$99.1K
GEHC icon
35
GE HealthCare
GEHC
$32.4B
$960K 0.4%
14,104
+1,861
+15% +$135K
AWK icon
36
American Water Works
AWK
$26.9B
$954K 0.4%
7,702
+78
+1% +$10.9K
PEP icon
37
PepsiCo
PEP
$190B
$928K 0.39%
5,475
+380
+7% +$69K
CMCSA icon
38
Comcast
CMCSA
$90B
$922K 0.38%
20,788
-2,562
-11% -$114K
GILD icon
39
Gilead Sciences
GILD
$165B
$885K 0.37%
11,807
+344
+3% +$26.5K
REGN icon
40
Regeneron Pharmaceuticals
REGN
$80.8B
$879K 0.37%
1,068
-72
-6% -$56.6K
FMC icon
41
FMC
FMC
$1.33B
$858K 0.36%
12,805
+2,258
+21% +$196K
XYL icon
42
Xylem
XYL
$28.1B
$827K 0.34%
9,082
+415
+5% +$42.8K
TMO icon
43
Thermo Fisher Scientific
TMO
$220B
$815K 0.34%
1,610
-20
-1% -$10.7K
VRTX icon
44
Vertex Pharmaceuticals
VRTX
$126B
$803K 0.33%
2,308
-39
-2% -$13.6K
J icon
45
Jacobs Solutions
J
$17B
$777K 0.32%
6,880
-1,098
-14% -$118K
DIS icon
46
Walt Disney
DIS
$181B
$774K 0.32%
9,554
+544
+6% +$46.5K
T icon
47
AT&T
T
$163B
$771K 0.32%
51,321
+6,956
+16% +$102K
BSX icon
48
Boston Scientific
BSX
$71.5B
$692K 0.29%
13,100
+709
+6% +$37.2K
HD icon
49
Home Depot
HD
$355B
$684K 0.28%
2,264
-282
-11% -$90.7K
LH icon
50
Labcorp
LH
$25.9B
$633K 0.26%
3,149
-1,103
-26% -$233K
1
2
3 4 5

Similar funds

MWM
Momentous Wealth Management Vancouver, Washington $175M AUM 14.91% 1-Year Est. Return
BCVI
Bain Capital Venture Investors Boston, Massachusetts $175M AUM 21.91% 1-Year Est. Return
CC
Converium Capital Montreal $175M AUM
BW
Basepoint Wealth Cedar Rapids, Iowa $175M AUM 43.04% 1-Year Est. Return
DWA
Delos Wealth Advisors Dallas, Texas $175M AUM 19.35% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Humankind Investments's Q3 2023 Portfolio in Review

As of Q3 2023, Humankind Investments held 123 positions worth $240M, down 6.1% from $256M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Humankind Investments's Q3 2023 filing shows 1 new, 43 increased, 64 reduced and 8 closed positions. Its largest new stake was Lumen: 10,845 shares worth $15.4K. The largest sale was Eli Lilly, an estimated $645K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Humankind Investments's largest Q3 2023 buy was Lumen: 10,845 shares worth $15.4K.
  • Humankind Investments added most to Corteva in Q3 2023, an estimated $249K increase.
  • Humankind Investments's biggest Q3 2023 reduction was Eli Lilly, cutting an estimated $645K.
  • Humankind Investments fully exited Tenet Healthcare in Q3 2023, selling an estimated $217K.
  • Humankind Investments's ten largest holdings make up 67% of its $240M portfolio in Q3 2023.
  • Humankind Investments opened 1 new position and closed 8 in Q3 2023.
  • Humankind Investments's portfolio value fell 6.1% quarter-over-quarter to $240M.

Based on Humankind Investments's 13F filing for Q3 2023, filed 13 Nov 2023.